258 related articles for article (PubMed ID: 16327153)
1. Curcuma longa extract protects against gastric ulcers by blocking H2 histamine receptors.
Kim DC; Kim SH; Choi BH; Baek NI; Kim D; Kim MJ; Kim KT
Biol Pharm Bull; 2005 Dec; 28(12):2220-4. PubMed ID: 16327153
[TBL] [Abstract][Full Text] [Related]
2. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
3. Isoliquiritigenin selectively inhibits H(2) histamine receptor signaling.
Kim DC; Choi SY; Kim SH; Yun BS; Yoo ID; Reddy NR; Yoon HS; Kim KT
Mol Pharmacol; 2006 Aug; 70(2):493-500. PubMed ID: 16675659
[TBL] [Abstract][Full Text] [Related]
4.
Kim JY; Jang SS; Lee JL; Sim JH; Shim JJ
Prev Nutr Food Sci; 2019 Jun; 24(2):159-164. PubMed ID: 31328120
[No Abstract] [Full Text] [Related]
5. Extremely early onset of ranitidine action on human histamine H2 receptors expressed in HEK293 cells.
Fukushima Y; Ishikawa T; Saitoh T; Tateishi K; Ogihara T; Fujishiro M; Shojima N; Honda M; Kushiyama A; Anai M; Sakoda H; Ono H; Onishi Y; Otsuka H; Katagiri H; Nagai R; Omata M; Asano T
Digestion; 2003; 68(2-3):145-52. PubMed ID: 14671421
[TBL] [Abstract][Full Text] [Related]
6. Pentagastrin gastroprotection against acid is related to H2 receptor activation but not acid secretion.
Tanaka S; Akiba Y; Kaunitz JD
Gut; 1998 Sep; 43(3):334-41. PubMed ID: 9863477
[TBL] [Abstract][Full Text] [Related]
7. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M
Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685
[TBL] [Abstract][Full Text] [Related]
8. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
9. Gastroprotective effect of standardized leaf extract from Argyreia speciosa on experimental gastric ulcers in rats.
Jaiswal SK; Rao CV; Sharma B; Mishra P; Das S; Dubey MK
J Ethnopharmacol; 2011 Sep; 137(1):341-4. PubMed ID: 21658440
[TBL] [Abstract][Full Text] [Related]
10. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
11. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)].
Scheen AJ
Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183
[TBL] [Abstract][Full Text] [Related]
12. Antisecretory and antiulcer effect of the H2-receptor antagonist famotidine in the rat: comparison with ranitidine.
Scarpignato C; Tramacere R; Zappia L
Br J Pharmacol; 1987 Sep; 92(1):153-9. PubMed ID: 2889492
[TBL] [Abstract][Full Text] [Related]
13. Histamine H2-receptor antagonism of T-593, an anti-ulcer agent: studies on aminopyrine accumulation in isolated canine gastric mucosal cells.
Inoie M; Marubuchi S; Arai H
Jpn J Pharmacol; 1998 Nov; 78(3):313-22. PubMed ID: 9869265
[TBL] [Abstract][Full Text] [Related]
14. Prevention of gastric ulcer relapse induced by indomethacin in rats by a mutein of basic fibroblast growth factor.
Satoh H; Asano S; Maeda R; Murakami I; Inada I; Sato F; Shino A
Jpn J Pharmacol; 1997 Mar; 73(3):229-41. PubMed ID: 9127818
[TBL] [Abstract][Full Text] [Related]
15. Effect of BMY-25368, a potent and long-acting histamine H2-receptor antagonist, on gastric secretion and aspirin-induced gastric lesions in the dog.
Cavanagh RL; Buyniski JP
Aliment Pharmacol Ther; 1989 Jun; 3(3):299-313. PubMed ID: 2577694
[TBL] [Abstract][Full Text] [Related]
16. Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Drozdowicz D; Kwiecieñ S; Pajdo R; Bielanski W; Hahn EG
Eur J Pharmacol; 2000 Jun; 398(1):147-58. PubMed ID: 10856459
[TBL] [Abstract][Full Text] [Related]
17. A possible molecular basis for the effect of gastric anti-ulcerogenic drugs.
Balint GA
Trends Pharmacol Sci; 1998 Oct; 19(10):401-3. PubMed ID: 9803829
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of
Khémiri I; Bitri L
Oxid Med Cell Longev; 2019; 2019():1568720. PubMed ID: 31827668
[TBL] [Abstract][Full Text] [Related]
19. Anti-ulcer compound from Voacanga africana with possible histamine H2 receptor blocking activity.
Tan PV; Nyasse B
Phytomedicine; 2000 Dec; 7(6):509-15. PubMed ID: 11194180
[TBL] [Abstract][Full Text] [Related]
20. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
Del Soldato P; Ghiorzi A; Cereda E; Donetti A
Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
